Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the...Read More
Thanks to a grant from JDRF, Rice University (TX) bioengineers, Drs. Omid Veiseh and Jordan Miller are combining cell-based therapy applications with sophisticated 3D-printed technologies to help the cells continue to flourish and produce insulin.
Our 28 young lobbyists wowed the Parliamentarians and helped them understand the struggles and needs of Canadians living with Type 1 Diabetes.
As someone directly touched by type 1 diabetes, I hope you will join me on this journey as we continue to invest in the advancement of T1D research.
While frequent meetings with a health care provider result in better glucose control, it is often hard for individuals and families to commit to the traditional health care’s rigorous schedules and long waiting lists.
"We're all in!" How one veteran bank exec went from having no connection to type 1 to JDRF Global Legacy Challenge sponsor
RBC executive Matt Varey returned to Canada with his family, after working for the bank in Switzerland. He didn’t know it yet, but his life was about to change – and not just because of the move. “When I got back, my job was national in nature and I travelled the country to get to ...
With the holidays fast approaching, it’s time to start thinking about what to get those special people in your life.
In a fast-faced world where technology is forever evolving, it is not always easy to stay abreast of the latest apps* designed for people living with type 1 diabetes (T1D). So here are some of this year’s top-rated, free diabetes apps to help you better navigate the world of carb counting, glu...
Getting a restful night’s sleep is often an elusive goal for many. Yet for someone living with type 1 diabetes (T1D), it can be more worrisome than challenging given the risk of hypoglycemia (low blood sugar). In fact, a new research study reveals that hypoglycemia can also induce abnormal hea...
A researcher from Milan, Italy has discovered that neutrophils – a type of white blood cell that forms an essential part of the immune system – can help identify triggers and predictors of progression to type 1 diabetes (T1D).